Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2018, Article ID 4812703, 7 pages
https://doi.org/10.1155/2018/4812703
Research Article

Prognostic Analysis of Duodenal Gastrointestinal Stromal Tumors

1Department of Gastroenterology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
2Department of Cadre Ward, Fujian Medical Union Hospital, Fujian, China

Correspondence should be addressed to Zhengting Wang; moc.621@gnaw_ekad and Jie Zhong; moc.liamtoh@46jzymmij

Received 12 May 2017; Revised 1 September 2017; Accepted 10 September 2017; Published 20 February 2018

Academic Editor: Giovanni D. De Palma

Copyright © 2018 Liwen Hong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Poveda, X. G. del Muro, J. A. López-Guerrero et al., “GEIS 2013 guidelines for gastrointestinal sarcomas (GIST),” Cancer Chemotherapy and Pharmacology, vol. 74, no. 5, pp. 883–898, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Yang, C. Jin, Z. Du et al., “Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes,” American Journal of Surgery, vol. 206, no. 3, pp. 360–367, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Sugase, T. Takahashi, K. Nakajima et al., “Clinicopathological characteristics, surgery and survival outcomes of patients with duodenal gastrointestinal stromal tumors,” Digestion, vol. 94, no. 1, pp. 30–36, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Miettinen and J. Lasota, “Gastrointestinal stromal tumors: pathology and prognosis at different sites,” Seminars in Diagnostic Pathology, vol. 23, pp. 70–83, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Fan, J. Zhong, Z. T. Wang et al., “Prognostic factors and outcome of resected patients with gastrointestinal stromal tumors of small intestine,” Medical Oncology, vol. 28, Supplement 1, pp. S185–S188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Søreide, O. M. Sandvik, J. A. Søreide, V. Giljaca, A. Jureckova, and V. R. Bulusu, “Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies,” Cancer Epidemiology, vol. 40, pp. 39–46, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. J. D. Reith, J. R. Goldblum, R. H. Lyles, and S. W. Weiss, “Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome,” Modern Pathology, vol. 13, pp. 577–585, 2000. View at Publisher · View at Google Scholar
  8. C. Shen, H. Chen, Y. Yin et al., “Duodenal gastrointestinal stromal tumors: clinicopathological characteristics, surgery, and long-term outcome,” BMC Surgery, vol. 15, no. 1, pp. 1–7, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Tornillo, “Gastrointestinal stromal tumor - an evolving concept,” Frontiers in Medicine, vol. 1, p. 43, 2014. View at Publisher · View at Google Scholar
  10. C. Colombo, U. Ronellenfitsch, Z. Yuxin et al., “Clinical, pathological and surgical characteristics of duodenal gastrointestinal stromal tumor and their influence on survival: a multi-center study,” Annals of Surgical Oncology, vol. 19, pp. 3361–3367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. F. M. Johnston, P. J. Kneuertz, J. L. Cameron et al., “Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis,” Annals of Surgical Oncology, vol. 19, pp. 3351–3360, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Yip, J. Zalcberg, S. Ackland et al., “Controversies in the management of gastrointestinal stromal tumors,” Asia-Pacific Journal of Clinical Oncology, vol. 10, no. 3, pp. 216–227, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Rutkowski, Z. I. Nowecki, W. Michej et al., “Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor,” Annals of Surgical Oncology, vol. 14, pp. 2018–2027, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. I. H. Kim, S. G. Kwak, and H. D. Chae, “Prognostic factors of patients with gastric gastrointestinal stromal tumor after curative resection: a retrospective analysis of 406 consecutive cases in a multicenter study,” European Surgical Research, vol. 55, no. 1-2, pp. 12–23, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Caterino, L. Lorenzon, N. Petrucciani et al., “Gastrointestinal stromal tumors: correlation between symptoms at presentation, tumor location and prognostic factors in 47 consecutive patients,” World Journal of Surgical Oncology, vol. 9, no. 1, p. 13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. R. P. Dematteo, J. S. Gold, L. Saran et al., “Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST),” Cancer, vol. 112, pp. 608–615, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Miettinen, L. H. Sobin, and J. Lasota, “Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up,” The American Journal of Surgical Pathology, vol. 29, pp. 52–68, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Iesalnieks, P. Rümmele, W. Dietmaier et al., “Factors associated with disease progression in patients with gastrointestinal stromal tumors in the pre-imatinib era,” American Journal of Clinical Pathology, vol. 124, pp. 740–748, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. N. A. Wong, R. Young, R. D. Malcomson et al., “Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach,” Histopathology, vol. 43, pp. 118–126, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Marano, V. Boccardi, D. Marrelli, and F. Roviello, “Duodenal gastrointestinal stromal tumor: from clinicopathological features to surgical outcomes,” European Journal of Surgical Oncology, vol. 41, no. 7, pp. 814–822, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. R. P. DeMatteo, K. V. Ballman, C. R. Antonescu et al., “Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial,” Annals of Surgery, vol. 258, no. 3, p. 422, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Li, Z. Li, L. Zhang et al., “Perioperative imatinib therapy in the treatment of patients with middle-high risk gastrointestinal stromal tumor,” Chinese Journal of Gastrointestinal Surgery, vol. 16, no. 3, 2013. View at Google Scholar
  23. R. P. Dematteo, K. V. Ballman, C. R. Antonescu et al., “Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial,” Lancet, vol. 373, no. 9669, pp. 1097–1104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. M. Van der Zwan and R. P. DeMatto, “Gastrointestinal stromal tumor: 5 years later,” Cancer, vol. 104, pp. 1781–1788, 2005. View at Publisher · View at Google Scholar · View at Scopus